Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Corcept Therapeutics Inc

+ Add to Watchlist


5.8400 USD 0.0400 0.68%

As of 20:10:00 ET on 05/22/2015.

Company Profile for Corcept Therapeutics Inc (CORT)

Corcept Therapeutics Inc. is a pharmaceutical company that discovers and develops drugs for the treatment of severe metabolic and psychiatric disorders. The Company's lead product modulates the effect of cortisol, also known as the "stress hormone", by selectively blocking the binding of cortisol to one of its two known receptors, the GR-II receptor.

Contact Information

Corcept Therapeutics Inc

149 Commonwealth Drive
Menlo Park, CA 94025
United States
Phone: 1-650-327-3270
Fax: 1-650-327-3218

Key Executives for Corcept Therapeutics Inc (CORT)

Joseph K BelanoffPresident/CEO/Co-FounderGary Charles Robb "Charlie"CFO/Secretary
Steven LoSenior VP/Chief Commercial OfcrAnne M LedouxVP/Chief Acctg Officer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil